SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0000950123-11-013818
Filing Date
2011-02-14
Accepted
2011-02-14 19:17:07
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G AMENDMENT 1 c12499sc13gza.htm SC 13G/A 39018
  Complete submission text file 0000950123-11-013818.txt   40844
Mailing Address 4225 EXECUTIVE SQUARE SUITE 485 LA JOLLA CA 92037
Business Address 4225 EXECUTIVE SQUARE SUITE 485 LA JOLLA CA 92037 (858) 457-5300
TRANSDEL PHARMACEUTICALS INC (Subject) CIK: 0001360214 (see all company filings)

IRS No.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-83793 | Film No.: 11610756
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O TRANSDEL PHARMACEUTICALS, INC. 4225 EXECUTIVE SQUARE, SUITE 485 LA JOLLA CA 92037
Business Address
Grasela John (Filed by) CIK: 0001456451 (see all company filings)

Type: SC 13G/A